|
CNOT3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.958100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.113990E-02 |
| Normal-vs-Stage2 |
6.826000E-02 |
| Normal-vs-Stage3 |
2.881800E-01 |
| Normal-vs-Stage4 |
1.322620E-01 |
| Stage1-vs-Stage2 |
8.939600E-01 |
| Stage1-vs-Stage3 |
3.840800E-01 |
| Stage1-vs-Stage4 |
9.966400E-01 |
| Stage2-vs-Stage3 |
4.477600E-01 |
| Stage2-vs-Stage4 |
9.318800E-01 |
| Stage3-vs-Stage4 |
5.840200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.883600E-02 |
| Normal-vs-AfricanAmerican |
2.730400E-02 |
| Normal-vs-Asian |
6.808400E-01 |
| Caucasian-vs-AfricanAmerican |
6.480200E-01 |
| Caucasian-vs-Asian |
2.708000E-01 |
| AfricanAmerican-vs-Asian |
1.461190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.312400E-02 |
| Normal-vs-Female |
8.559800E-01 |
| Male-vs-Female |
1.892320E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.390100E-02 |
| Normal-vs-Extreme_Weight |
2.352000E-02 |
| Normal-vs-Obese |
2.637000E-01 |
| Normal-vs-Extreme_Obese |
3.544800E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.055200E-01 |
| Normal_Weight-vs-Obese |
4.294800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.433230E-01 |
| Extreme_Weight-vs-Obese |
2.597400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.383800E-01 |
| Obese-vs-Extreme_Obese |
7.186400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.891600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.542600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.135900E-03 |
| Normal-vs-Age(81-100Yrs) |
5.635400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.408400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.029700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.177710E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.634300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.654200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.770200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.960550E-01 |
| Normal-VS-Type2 PRCC |
3.23339999996897E-06 |
| Normal-VS-KIRP CIMP |
6.315600E-01 |
| Normal-VS-Unclassified PRCC |
1.860770E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.5405999999627E-06 |
| Type1 PRCC-VS-KIRP CIMP |
3.239800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.148600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.959000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.882900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.087000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.581800E-03 |
| Normal-vs-N1 |
9.004000E-01 |
| Normal-vs-N2 |
8.405200E-01 |
| N0-vs-N1 |
2.765600E-02 |
| N0-vs-N2 |
3.150000E-01 |
| N1-vs-N2 |
9.193200E-01 |
|
|
